Logos Global Management LP Amicus Therapeutics, Inc. Transaction History

Logos Global Management LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$7.89 - $12.48 $4.93 Million - $7.8 Million	-625,000 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$9.82 - $12.44 $6.14 Million - $7.78 Million	625,000 New	625,000 $7.22 Million
Q2 2020 Aug 14, 2020	SELL	$8.86 - $15.69 $3.96 Million - $7.01 Million	-446,882 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$6.63 - $11.16 $2.96 Million - $4.99 Million	446,882 New	446,882 $4.13 Million

298

321M

355K

456K

Ticker FOLD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 280,497,984
Market Cap $2.94B
Description
Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...

Get notified when there are updates to the investment portfolio of Logos Global Management LP, based on Form 13F filings with the SEC.

Stay updated on Logos Global Management LP with notifications on news.